Comparing Bronchodilation of Symbicort With and Without Valved Holding Chamber (Aerochamber Plus)
Status:
Completed
Trial end date:
2009-08-01
Target enrollment:
Participant gender:
Summary
This study will compare the amount of bronchial tube relaxation from the Formoterol medicine
contained in the Symbicort pressure Metered Dose Inhaler(pMDI)(a combination of Budesonide, a
steroid, and Formoterol, a drug which relaxes the bronchial smooth muscle. The comparison
will be using the pMDI in the usual fashion to the pMDIs and a spacer which allows more time
for breathing in the medication. Breathing tests will be measured over a 12 hour period for
the comparison.
Phase:
Phase 4
Details
Lead Sponsor:
Western Sky Medical Research
Collaborator:
AstraZeneca
Treatments:
Budesonide Budesonide, Formoterol Fumarate Drug Combination